Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| groups:relogio:people:monica_abreu [2015/09/12 13:26] – [Publications] relogio | groups:relogio:people:monica_abreu [2018/01/30 11:36] (current) – removed relogio | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | ====== Mónica Abreu ====== | ||
| - | |||
| - | {{ : | ||
| - | |||
| - | Charité Medical University of Berlin | ||
| - | |||
| - | IRI Graduate School | ||
| - | |||
| - | Institute for Theoretical Biology (ITB) | ||
| - | |||
| - | Room 1324 | ||
| - | |||
| - | Invalidenstraße 43 | ||
| - | |||
| - | 10115 Berlin | ||
| - | |||
| - | phone: +49 30 2093 8496 (office) | ||
| - | |||
| - | +49 30 450 559 196 (office-lab) | ||
| - | |||
| - | +49 30 450 559 135 (lab) | ||
| - | |||
| - | < | ||
| - | |||
| - | |||
| - | |||
| - | ====== Curriculum vitae ====== | ||
| - | |||
| - | | ||
| - | |||
| - | **2012 - 2014** | ||
| - | |||
| - | **2009 - 2012** | ||
| - | |||
| - | **2004 - 2008** | ||
| - | |||
| - | |||
| - | ====== Interests ====== | ||
| - | |||
| - | |||
| - | |||
| - | Circadian clock, Core-clock network, Cancer immunology. | ||
| - | |||
| - | ====== Projects ====== | ||
| - | |||
| - | |||
| - | |||
| - | // | ||
| - | |||
| - | //**LRRK2 role on auto-antibody production by human B cells**// - Michael J. Fox Foundation and Immunology Group, Center for Neurosciences and Cell Biology, University of Coimbra, Portugal | ||
| - | |||
| - | **//Role of Natural Killer cells in Mycobacterium tuberculosis infection to pulmonary disease//** - M.Sc. thesis, Faculty of Medicine, University of Coimbra, Portugal | ||
| - | |||
| - | **//Natural Killer cells in Rheumatoid arthritis// | ||
| - | |||
| - | **// | ||
| - | |||
| - | **// | ||
| - | |||
| - | ====== Publications ====== | ||
| - | == Alterations in the peripheral blood B cell subpopulations of multidrug resistant tuberculosis patients. == | ||
| - | |||
| - | **__ Abreu M__**, Helena Carvalheiro, | ||
| - | |||
| - | **[[http:// | ||
| - | |||
| - | ==The need for transparency and good practices in the qPCR literature.== | ||
| - | |||
| - | Bustin SA, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley G, Wittwer CT, Schjerling P, Day PJ, **__Abreu M__**, //et al//..** //Nat Methods// 2013** | ||
| - | |||
| - | **[[http:// | ||
| - | |||
| - | |||
| - | | ||
| - | ==Expression of CD62L, CD27 and CD11b define a marked cytotoxic effector role for NK cells in rheumatoid arthritis.== | ||
| - | | ||
| - | **__Abreu M__**, Carvalheiro H, Duarte C, Pereira da Silva JÁ, Souto-Carneiro MM, Rodrigues-Santos P. **//Ann Rheum Dis// 2011** | ||
| - | |||
| - | |||
| - | **[[http:// | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||